Cargando…

Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

Introduction The clinical course of non-alcoholic fatty liver disease (NAFLD) in its long term may follow a benign course or have an adverse outcome leading to hepatocellular carcinoma (HCC) or end-stage liver disease requiring liver transplantation. Such patients represent only a small proportion o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumari, Bandana, Sharma, Sadhana, Kumar, Ramesh, Dipankar, Satish, Naik, Bijaya N, Banerjee, Ayan, Kumar, Sushil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830306/ https://www.ncbi.nlm.nih.gov/pubmed/35165568 http://dx.doi.org/10.7759/cureus.21110

Ejemplares similares

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2021)

Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis
por: Wang, Huali, et al.
Publicado: (2020)

Association between red cell distribution width-to-platelet ratio and hepatic fibrosis in nonalcoholic fatty liver disease: A cross-sectional study
por: Zhou, Wen-Jie, et al.
Publicado: (2019)

Prognostic Values of Platelet Distribution Width and Platelet Distribution Width-to-Platelet Ratio in Severe Burns
por: Lin, Jian-Chang, et al.
Publicado: (2022)

Relation Between HbA1c and Lipid Profile Among Prediabetics, Diabetics, and Non-diabetics: A Hospital-Based Cross-Sectional Analysis
por: Kumar, Sushil, et al.
Publicado: (2022)

Gamma‐Glutamyl Transpeptidase‐to‐Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease
por: Luo, Jie, et al.
Publicado: (2022)

Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: A systematic review and meta-analysis
por: Cai, Ying, et al.
Publicado: (2019)

Treatment of Fatty Liver Disease: The Present and the Future
por: Ramanan, Sruthi Priyavadhana, et al.
Publicado: (2021)

Platelet-to-Portal Vein Width Ratio and Platelet-to-Spleen Thickness Ratio Can Be Used to Predict Progressive Liver Fibrosis Among Patients With HBV Infection With HBeAg-Negativity and a Normal ALT Level
por: Feng, Mudan, et al.
Publicado: (2022)

Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease?
por: Agilli, Mehmet, et al.
Publicado: (2014)

The second wave of COVID-19 wreaked havoc: A look at clinical and laboratory parameters of survivors and non-survivors admitted to Intensive Care Unit, a single-centered retrospective study
por: Kumari, Bandana, et al.
Publicado: (2023)

The Role of Indirect Immunofluorescence (IIF) and Line Immunoassay (LIA) in the Diagnosis of Autoimmune Diseases and Their Clinical Correlation: An Observational Study From a Tertiary Care Center in Bihar
por: Kumar, Avinash, et al.
Publicado: (2023)

The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease
por: Li, Qiang, et al.
Publicado: (2017)

Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI)
por: Wan, Minjie, et al.
Publicado: (2021)

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?
por: Parsian, Hadi
Publicado: (2011)

Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease
por: Anania, Caterina, et al.
Publicado: (2011)

Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Jung, Chan-Hee, et al.
Publicado: (2020)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
por: Adler, Michael
Publicado: (2011)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

A Syndrome of Variable Allergy, Short Stature, and Fatty Liver
por: Qiao, Jing, et al.
Publicado: (2022)

Advances in genetic variation in metabolism-related fatty liver disease
por: Shi, Fan, et al.
Publicado: (2023)

Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis B
por: Purkayastha, Subham, et al.
Publicado: (2023)

The Ratio of the Hemoglobin to Red Cell Distribution Width Combined with the Ratio of Platelets to Lymphocytes Can Predict the Survival of Patients with Gastric Cancer Liver Metastasis
por: Zhai, Zhao, et al.
Publicado: (2021)

The Co-occurrence of Chronic Hepatitis B and Fibrosis Is Associated With a Decrease in Hepatic Global DNA Methylation Levels in Patients With Non-alcoholic Fatty Liver Disease
por: Li, FangYuan, et al.
Publicado: (2021)

Semen Quality in Males Suffering From COVID-19: A Pilot Study
por: Dipankar, Satish P, et al.
Publicado: (2022)

Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases
por: Kumari, Bandana, et al.
Publicado: (2022)

Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study
por: Oral, Alihan, et al.
Publicado: (2019)

Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients
por: Milovanovic Alempijevic, Tamara, et al.
Publicado: (2017)

Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease
por: Sabotta, Caroline M., et al.
Publicado: (2022)

Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease
por: Wu, Chutian, et al.
Publicado: (2021)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022)

Diagnostic value of red blood cell distribution width, platelet distribution width, and red blood cell distribution width to platelet ratio in children with hemophagocytic lymphohistiocytosis
por: Xi, Ya, et al.
Publicado: (2021)

Non-invasive assessment of liver fibrosis in alcoholic liver disease
por: Husain, Ayan, et al.
Publicado: (2020)

The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer
por: Takeuchi, Hideya, et al.
Publicado: (2017)

Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
por: Sirli, Roxana, et al.
Publicado: (2011)

Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)

Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver
por: Kusumawati, Ninung RD, et al.
Publicado: (2013)

The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer
por: Qiu, Ting, et al.
Publicado: (2022)

Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease
por: Yu, Xiaoxiao, et al.
Publicado: (2023)

Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eush45bhhor0immdjgoj7rfgj1